In their recent report, the Ontario Bioscience Innovation Organization (OBIO), a non-profit dedicated to positioning the province as a world leader in health science technology, declared that in order to capitalize on the $9-Trillion dollar Global Health Economy, Canada must facilitate an environment of innovation and growth. The report stated that Canadian companies are competitive players but not differentiated, ultimately making it difficult to stand out on a global stage.
But the Ottawa start-up community is ready to change this. Strong government support and leading academic institutions offer a wide talent pool, research facilities, and funding possibilities to companies in the Nation’s capital. As an example, MedDev Commercialization Centre (MDCC) is helping corporations bring their products to the global market by reducing barriers to commercialization. The City of Ottawa is bolstering innovation, and Invest Ottawa is facilitating relationships for the Life Sciences sector in foreign markets.
It’s perfect timing for Ottawa’s Spartan Bioscience to bring its next-generation device to the market.